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Available online 26 May 2016Background: Skeletal muscle is important to determine physical activity and exercise capacity in cardiovascular
disease. This study aims to investigate the relationship between skeletal muscle volumemeasured by bioelectri-
cal impedance analysis and ventilation indices assessed by cardiopulmonary exercise test in patients with
myocardial infarction.
Methods: A total of 60 patients (57 men; 59 ± 9 years) who underwent percutaneous coronary intervention for
ST-elevation myocardial infarction were enrolled into this study. All patients performed cardiac rehabilitation
and then achieved physical activity of daily life. No patient was complicated by diabetes mellitus. In symptom-
limited cardiopulmonary exercise test, minute ventilation ( _VE), oxygen consumption ( _VO2), and carbon dioxide
production ( _VCO2) were continuously obtained. A volume of skeletal muscle measured by bioelectrical imped-
ance analysis was normalized for height (skeletal muscle index).
Results: The skeletal muscle index showed a signiﬁcant inverse correlation with peak _VE/ _VO2 (p = 0.02,
r =−0.39) and peak _VE/ _VCO2 (p= 0.02, r =−0.30). In addition, the skeletal muscle index inversely correlated
with _VE/ _VCO2 slope (p = 0.02, r =−0.30). On the other hand, the skeletal muscle index did not signiﬁcantly
correlate with peak _VO2 (p= 0.56, r = 0.08) and peak _VCO2 (p = 0.99, r = 0.001). Besides, the skeletal muscle
index did not signiﬁcantly correlate with Δ _VO2/Δwork rate slope (p = 0.60, r = 0.07).
Conclusions: The increase in skeletalmuscle indexwas associatedwith the amelioration of ventilatory efﬁcacy to ex-
ercise at the peak level. Furthermore, the increase in skeletal muscle index may account for favorable prognosis.
Theseﬁndings could strengthen the role of skeletalmuscle in exercise capacity of patientswithmyocardial infarction.
© 2016 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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Impaired capacity of physical function is associated with morbidity
and mortality in cardiovascular disease [1,2]. Exercise capacity was an
independent predictor of mortality in thrombolysed patients for acute
myocardial infarction [3]. In heart failure, the limited exercise capacity
was determined by peripheral hemodynamics rather than central he-
modynamics [4,5]. In this regard, skeletal muscle played an important
role in determining anaerobic metabolism during exercise in patients
with chronic heart failure [6,7]. Previous studies showed that decreased
blood ﬂow to the skeletal muscle [8] and alteredmetabolism in skeletal
muscle [9,10] were closely associated with exercise intolerance.
Bioelectrical impedance analysis (BIA) allows the determination of
body compositions [11]. The use of BIA has been widespread in clinicalular and Respiratory Medicine,
, Japan.
ayashi).
land Ltd. This is an open access articlpractice [12].With the technical progress of BIA, it is feasible tomeasure
skeletal muscle volume with the convenient method [13,14]. However,
whether skeletal muscle volumemeasured by this simple method is as-
sociated with exercise capacity is unknown. Cardiopulmonary exercise
testing (CPET) is a remarkably versatile tool that can assess exercise
capacity, which quantitatively measures the consumption of oxygen
and the production of carbon dioxide [15]. Besides, CPET precisely pro-
vides detailed information on ventilatory response to exercise and prog-
nosis in patients with cardiovascular disease [16,17].
Therefore, this study aims to investigate the relationship between
skeletal muscle volume measured by BIA and ventilation indices
assessed by CPET in patients with myocardial infarction.
2. Methods
2.1. Study population
This study enrolled patients who underwent percutaneous coronary
intervention for ST-elevation myocardial infarction in the Hospital ofe under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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were excluded from this study. All patients enrolled in this study per-
formed cardiac rehabilitation before performing progressively increas-
ing, symptom-limited CPET. Patients' physical activities were in New
York Heart Association (NYHA) functional class II or III, when CPET
was performed. Each patient's drug therapy was optimized before the
entry into this study. Patients did not have pulmonary rale and were
clinically stable before the study. Patients with severe concomitant
extracardiac disease limiting exercise performance were excluded
from this study. The study protocol conforms to the ethical guidelines
of the 1975 Declaration of Helsinki as reﬂected in a priori approval by
the institution's human research committee and informed consent
was obtained from all patients enrolled in this study.2.1.1. Body composition measurement
Body composition was assessed using 8-electrode segmental bio-
electrical impedance analysis (X-SCAN PLUS, Tanita Co., Tokyo, Japan)
in a standing posture before exercise. The total volume of skeletal mus-
cle and the skeletal muscle volume in each upper and lower limb was
also measured under a fasting condition. Body weight and height were
simultaneously measured, providing skeletal muscle index (the weight
in kilograms divided by the square of the height in meters).Table 1
Medication use.
Drugs No. of patients
Angiotensin-converting enzyme inhibitor 37 (62)
Angiotensin receptor blocker 18 (30)
Calcium antagonist 3 (5)
β blocker 39 (65)
Loop diuretic 10 (17)
Aldosterone receptor antagonist 26 (43)
Nitrate 10 (17)
Statin 46 (77)
Antiplatelet agent 53 (88)
Numbers are presented as N (%).2.2. CPET procedures and data collection
All patients underwent a familiarization bicycle exercise test before
performing CPET. Patients were instructed to exercise maximally to
symptomatic end points using an isokinetic ergometer (AEROBIKE
75XLII, Minato Medical Science Co. Ltd., Osaka, Japan) under medica-
tions. A mask was placed covering the nose and the mouth, the patient
breathed through a non-rebreathing valve. Air was delivered to the O2
and CO2 analyzer (AEROMONITOR 300S, Minato Medical Science Co.
Ltd., Osaka, Japan). Breath-by-breath gas exchange measurement was
performed, permitting continuous measurements of ventilation ( _VE),
oxygen uptake ( _VO2), and carbon dioxide production ( _VCO2) on-line.
The instrument was calibrated using reference gases before every test.
During the test, a standard 12-lead ECG (CASE, GE Healthcare, Wauwa-
tosa, WI, Wisconsin, and United States) was interfaced and heart
rhythm was monitored continuously throughout the exercise test.
Blood pressure was measured using a standard cuff sphygmomanome-
ter every 1min. After stationarywarm-upexercisewith an equivalent of
15 W for 3 min, a ramp protocol with incremental steps equivalent of
20W/min was used at a rate of approximately 50 rotation/min. All sub-
jects performed an active cool-down, at the initial workload of the exer-
cise protocol, for at least 3min after the cessation of ramping exercise. A
modiﬁed Borg scale was used to facilitate communication with the
patient with regard to symptoms. From the ventilatory data, minute
ventilation ( _VE), respiratory exchange ratio ( _VCO2/ _VO2), and ventilatory
equivalents for O2 and CO2 ( _VE/ _VO2, _VE/ _VCO2) were calculated. Peak
oxygen consumption (peak _VO2) was expressed as the highest attained
_VO2 during the ﬁnal 30 s of ramping exercise. Anaerobic threshold was
measured with the _V-slope analysis from the plot of _VCO2 versus _VO2 on
equal scales. The anaerobic threshold value was also conﬁrmed by ven-
tilatory equivalents (increase of _VE/ _VO2 with a constant _VE/ _VCO2) and
end-tidal pressure (increase of end-tidal _VO2 with constant end-tidal _V
CO2). The _VO2/work rate relationship was evaluated throughout the
entire exercise, during the ramping period, after elimination of the in-
crease in work rate during the ﬁrst 120 s to account for the time con-
stant for the _VO2 response to the work rate increase. The _VE versus _V
CO2 slope was calculated by linear regression, excluding the nonlinear
part of the data after the onset of ventilatory compensation formetabol-
ic acidosis. Exercise tests were supervised by an expert team consisting
of physiotherapists and physicianswhowere unaware of results of body
composition and echocardiography.2.3. Echocardiographic assessment
Echocardiography was performed using a 2.5-MHz transducer and
connected to computerized hemodynamic instruments. Examinations
were performed with the head of the examining table elevated about
30° in a partial decubitus position. Biplane left ventricular end-diastolic
and end-systolic volumes were measured using modiﬁed Simpson's
rule from paired apical 4-chamber and apical 2-chamber echocardio-
graphic images. Left ventricular ejection fraction (LVEF) was obtained
from the orthogonal apical views as a parameter of left ventricular sys-
tolic function. The parasternal acoustic window was used to record at
least 3 consecutive beats of 2-dimensional and M-mode recordings of
the left ventricular internal diameter and wall thicknesses just below
the tips of the anterior mitral valve leaﬂets in both the long- and short-
axis views. Pulsed-wave Doppler sample volume was placed at the
center of the mitral annulus from an apical view to record the early
phase of diastolic transmitral blood ﬂow (E). Left ventricular myocardial
velocitieswere evaluated by tissueDoppler imaging. Pulsed tissueDopp-
ler imaging was performed in an apical view to acquire the peak early
diastolic mitral annular velocity (e′). To avoid the inﬂuence of regional
function on the velocity, tissue Doppler signals were recorded at 2
sites: the septal and the lateral sides of the mitral annulus. The ratio of
E to e′ (E/e′) was calculated at the both sites, and then the average E/e′
of these was used for representing left ventricular diastolic function.
The measurements were composed by the average of ≥3 consecutive
cardiac cycles. Heart rate was simultaneously recorded.
2.4. Statistical analysis
Continuous variables are expressed as mean ± standard deviation
(SD) and categorical data are presented as numbers (percentages). A
linear regression analysis was applied to determine correlation between
skeletalmuscle index and ventilation indicesmeasured. A p value b0.05
was considered signiﬁcant.
3. Results
The study consisted of 60 consecutive patients (57 men; mean age,
59 ± 9 years). The underlying disease was hypertension in 20 patients
and dyslipidemia including familial hypercholesterolemia in 18 patients.
All patients had a history of smoking. Table 1 lists medication use.
Table 2 shows measurements of body composition, echocardiography,
and CPET. Skeletal muscle volume averaged 23.4 ± 4.4 kg, and skeletal
muscle index averaged 8.3 ± 1.5 kg/m2. Echocardiographic analysis
showed that left ventricular ejection fraction averaged 53.7 ± 9.3%, and
E/e′ averaged 10.1 ± 3.5. All patients performed CPET safely and without
any complications. Exercise duration excluding warm-up period was
294.4±69.9 s. The anaerobic thresholdwasmeasurable and themaximal
work was attained in all patients tested. The limiting symptom was leg
fatigue in all patients enrolled. The maximum load of ramping exercise
averaged 110.3 ± 23.1 W.
Table 2
Measures of body composition, echocardiography, and cardiopulmonary exercise
testing.
Body composition
Height (cm) 167.4 ± 6.3
Weight (kg) 65.4 ± 9.4
BMI (kg/m2) 23.3 ± 2.7
Skeletal muscle (kg) 23.4 ± 4.4
Skeletal muscle index (kg/m2) 8.3 ± 1.5
Echocardiography
LV end-diastolic diameter (mm) 51.8 ± 5.8
LV end-systolic diameter (mm) 36.5 ± 6.7
LV ejection fraction (%) 53.7 ± 9.3
E/e′ 10.1 ± 3.5
Cardiopulmonary exercise testing
Peak heart rate (beats/min) 124.4 ± 21.6
Peak work rate (W) 110.3 ± 23.1
Peak _VE (mL/kg/min) 716.6 ± 157.9
Peak _VO2 (mL/kg/min) 17.6 ± 3.9
Peak _VCO2 (mL/kg/min) 21.7 ± 5.0
Peak RER 1.2 ± 0.2
Peak Mets 5.0 ± 1.2
Peak _VE/ _VO2 (/kg) 0.7 ± 0.2
Peak _VE/ _VCO2 (/kg) 0.5 ± 0.2
_VE/ _VCO2 slope 27.8 ± 5.2
Δ _VO2/Δwork rate slope 7.4 ± 1.2
Values are mean ± SD. BMI = body mass index; V/S ratio = visceral to subcutaneous
fat ratio; LV= left ventricle; E=earlymitral inﬂowvelocity; e′=early diastolicmitral
annulusmotion velocity; _VO2=minute oxygen uptake; _VE=minute ventilation; _VCO2
= minute carbon dioxide production; respiratory exchange ratio = RER; metabolic
equivalents =Mets.
Fig. 2. Relation between skeletal muscle index and _VE/ _VCO2 slope.
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Fig. 1 shows a relation between skeletal muscle index and CPET pa-
rameters regarding ventilatory efﬁcacy to exercise. There were signiﬁ-
cantly inverse correlations between skeletal muscle index and peak _V
E/ _VO2 (r = −0.39, p = 0.002; Fig. 1A) and between skeletal muscle
index and peak _VE/ _VCO2 (r=−0.30, p=0.02; Fig. 1B). Skeletal muscle
index showed a signiﬁcant inverse correlation with _VE= _VCO2 slope (r=
0.30, p = 0.02; Fig. 2). However, no signiﬁcant correlations were found
between skeletal muscle index and peak _VE (r = 0.23, p = 0.08), be-
tween skeletal muscle index and peak _VO2 (r = 0.08, p = 0.56), be-
tween skeletal muscle index and peak _VCO2 (r = 0.001, p = 0.99),
and between skeletal muscle index and Δ _VO2/Δwork rate slope (r =
0.07, p = 0.60).
4. Discussion
Exercise is of value in primary, secondary, and tertiary prevention in
cardiovascular diseases. CPET is a remarkably versatile tool that pro-
vides valuable diagnostic and prognostic information regarding patients
with cardiovascular diseases [16,18]. In CPET, peak _VO2 (the highest rate
of oxygen uptake) and _VE/ _VCO2 slope (the rate of increase in ventilation
per unit increase in carbon dioxide production) are widely accepted as
useful prognostic markers [19,20]. Skeletal muscle plays an importantFig. 1. Relation between skeletal muscle index and peak _VE/ _VO2 (role in determining exercise capacity. In this study, we compared skele-
tal muscle indexwith various ventilation indices obtained from CPET in
patients withmyocardial infarction. Themajor ﬁndings of this study are
as follows: 1) skeletal muscle index was associated with the ameliora-
tion of ventilatory efﬁcacy at the peak level and 2) the inverse correla-
tion between skeletal muscle index and _VE/ _VCO2 slope suggests that
skeletal muscle index may be attributed to better prognosis.
It is undoubtedly necessary to perform cardiac rehabilitation in pa-
tients with cardiovascular disease. It is therefore essential to evaluate
exercise capacity for those patients. Skeletal muscle is one of the impor-
tant determinants of exercise capacity [5]. Previous studies have shown
fundamental mechanisms underlying exercise capacity in association
with skeletal muscle. Harrington et al. reported that muscular atrophy
in the lower limbs was a major determinant of exercise capacity [21].
Sullivan et al. reported that a decrease in type I ﬁbers and an increase
in type IIb ﬁbers of skeletal muscle were observed in heart failure [22]
and reduced aerobic enzyme activity in skeletal muscle was associated
with exercise intolerance in heart failure [6]. In addition, an intrinsic
muscle abnormality is considered to be responsible for exercise capaci-
ty. Impaired skeletal muscle function resulted in ergoreﬂex activation,
leading to increased ventilation [23], and depleted peripheral muscle
mass was associated with ergoreﬂex overactivity and exercise limita-
tion in heart failure [24]. Recently, Dhakal et al. demonstrated that utili-
zation of oxygen in skeletal muscle determined exercise capacity in
heart failure with preserved ejection fraction [25]. Consistent with the
previous reports, the present study showed that an increase in skeletal
muscle index ameliorated ventilatory efﬁcacy at peak exercise level in
patients with myocardial infarction. This is because skeletal muscle
index may reﬂect alteration of histology, metabolism, ergoreﬂex, and
oxygen consumption in this disorder. The novelty of the present study
is that simply measured skeletal muscle by BIA is attributed to exercise
capacity in terms of ventilatory efﬁcacy.
CPET provides valuable parameters: 1) peak _VO2 reﬂectingmaximal
cardiac output during exercise, 2) _VE/ _VCO2 slope reﬂecting cardio-
ventilatory function during exercise, 3) Δ _VO2/Δwork rate reﬂectingA) and between skeletal muscle index and peak _VE/ _VCO2 (B).
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and 4) anaerobic threshold reﬂecting exercise intensity at which lactic
acidosis occurs. _VE increases as a function of hyperbolic state. Above
the level of anaerobic threshold, lactic acidosis stimulates ventilation
further, thus leading to an increase in tidal volume to eliminate the
excessive production of CO2. Such ventilatory drive progressively in-
creases _VE/ _VO2 and _VE/ _VCO2, both of which indicate ventilatory equiv-
alent to O2 uptake and CO2 excretion, respectively. The ventilatory
equivalent markers are reﬂected by several factors such as lactic acido-
sis, hyperventilation, and chemosensitivity. In addition, increased _VE/ _V
CO2 during exercise was related to an increase in ventilation–perfusion
mismatch due to increased dead space ventilation in heat failure [26].
This study demonstrated inverse relation between skeletal muscle
index and peak _VE/ _VO2 and between skeletal muscle index and peak _V
E/ _VCO2, indicating that skeletal muscle was associated with the amelio-
ration of ventilatory efﬁcacy at the peak exercise level.
The steep slope of _VE/ _VCO2 slope is associated with multiple factors
such as reduced cardiac output during exercise, increased pulmonary
artery and capillary wedge pressures, increased dead space/tidal
volume ratio, and augmented chemoreceptor sensitivity. Thus, the in-
creased _VE/ _VCO2 slope is due to both ventilation–perfusion mismatch
arising from hemodynamic dysfunction and the altered control of
ventilation. Our study also demonstrated inverse relation between
skeletal muscle index and _VE/ _VCO2 slope, implying that skeletal muscle
may gain support of improvement of prognosis inmyocardial infarction.
Although both peak _VO2 and _VE/ _VCO2 slope are related to cardiovascular
prognosis, _VE/ _VCO2 slope is a better predictor of clinical outcomes than
peak _VO2 [19,20,27]. This is because peak _VO2 may not accurately reach
to a plateau level and is also affected by the motivation of patients. Our
study showed that skeletal muscle index was associated with _VE/ _VCO2
slope but not with peak _VO2, indicating that skeletal muscle index
may be associated with ventilatory efﬁcacy to exercise but not with
exercise capacity.
There are several limitations in this study. First, we measured
skeletal muscle quantitatively, but did not perform qualitative analysis
of skeletal muscle such as muscle power. Because the primary aim of
this study is to determine whether or not skeletal muscle measured
by BAI is clinically useful, we focused on the quantitative analysis of
skeletal muscle. Second, _VE/ _VO2 and _VE/ _VCO2 were standardized by
body weight in this study, because other ventilation indices were stan-
dardized in CPET.
Skeletal muscle is one of the pathophysiological links with exercise
capacity in cardiovascular disease. Despite this crucial association, the
detailedmechanisms are yet to be determined. Our study demonstrated
that skeletal muscle index inversely correlated with ventilatory efﬁcacy
at peak exercise level. In addition, skeletal muscle index negatively cor-
related with the best prognostic marker (i.e., _VE/ _VCO2 slope) obtained
from CPET. These ﬁndings can explain that skeletal muscle is intimately
associated with ventilatory response to exercise. However, further
studies are needed to elucidate the fundamental pathophysiological
mechanisms onwhich the role of skeletal muscle in ventilatory efﬁcacy
is based. In addition, it is necessary to study whether the increase in
skeletal muscle improves the prognosis in the population of the present
study.Conﬂict of interest
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